rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2010-9-9
|
pubmed:abstractText |
The clinical management of patients with renal cell carcinoma (RCC) remains difficult, and the development of new diagnostic, prognostic, and therapeutic tools is still required.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/CA9 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Carbonic Anhydrases,
http://linkedlifedata.com/resource/pubmed/chemical/G250 monoclonal antibody,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/Von Hippel-Lindau Tumor Suppressor...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1873-7560
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
75-83
|
pubmed:dateRevised |
2011-7-29
|
pubmed:meshHeading |
pubmed-meshheading:20359812-Antibodies, Monoclonal,
pubmed-meshheading:20359812-Antigens, Neoplasm,
pubmed-meshheading:20359812-Carbonic Anhydrases,
pubmed-meshheading:20359812-Carcinoma, Renal Cell,
pubmed-meshheading:20359812-Clinical Trials, Phase I as Topic,
pubmed-meshheading:20359812-Clinical Trials, Phase II as Topic,
pubmed-meshheading:20359812-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:20359812-Humans,
pubmed-meshheading:20359812-Kidney,
pubmed-meshheading:20359812-Kidney Neoplasms,
pubmed-meshheading:20359812-Mutation,
pubmed-meshheading:20359812-Prognosis,
pubmed-meshheading:20359812-Randomized Controlled Trials as Topic,
pubmed-meshheading:20359812-Tumor Markers, Biological,
pubmed-meshheading:20359812-Von Hippel-Lindau Tumor Suppressor Protein
|
pubmed:year |
2010
|
pubmed:articleTitle |
Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
|
pubmed:affiliation |
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. a.stillebroer@uro.umcn.nl
|
pubmed:publicationType |
Journal Article,
Review
|